Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Three Months of Rosuvastatin Treatment on Peripheral Endothelial Function, Inflammatory Markers in the Blood and the Skeletal Muscle and on Postnatal Vasculogenesis in Patients With Severe Chronic Heart Failure

NCT00176332 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT00176332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00176332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Three Months of Rosuvastatin Treatment on Peripheral Endothelial Function, Inflammatory Markers in the Blood and the Skeletal Muscle and on Postnatal Vasculogenesis in Patients With Severe Chronic Heart Failure
Lead sponsor
University of Leipzig
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
December 31, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure